Integrated structure-based activity prediction model of benzothiadiazines on various genotypes of HCV NS5b polymerase (1a, 1b and 4) and its application in the discovery of new derivatives.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2012-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2012.01.031PMID 22386565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development.

  2011cited by this paper
• QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine

  2011cited by this paper
• HCV NS5B polymerase inhibitors.

  2010cited by this paper
• NS5B RNA dependent RNA polymerase inhibitors: the promising approach to treat hepatitis C virus infections.

  2010cited by this paper
• 1a/1b Subtype Profiling of Nonnucleoside Polymerase Inhibitors of Hepatitis C Virus

  2010cited by this paper
• Insight into ligand selectivity in HCV NS5B polymerase: molecular dynamics simulations, free energy decomposition and docking

  2010cited by this paper
• Studies of benzothiadiazine derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.

  2010cited by this paper
• Review article: specifically targeted anti‐viral therapy for hepatitis C – a new era in therapy

  2010cited by this paper
• New NS5B polymerase inhibitors for hepatitis C

  2010cited by this paper
• Investigational drugs for hepatitis C

  2010cited by this paper
• Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges.

  2010cited by this paper
• Antiviral resistance and specifically targeted therapy for HCV (STAT‐C)

  2009cited by this paper
• Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS

  2009cited by this paper
• Approaches for the development of antiviral compounds: the case of hepatitis C virus.

  2009cited by this paper
• Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis

  2009cited by this paper
• CLiDE Pro: The Latest Generation of CLiDE, a Tool for Optical Chemical Structure Recognition

  2009cited by this paper
• 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase.

  2009cited by this paper
• Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors.

  2009cited by this paper
• QSAR Analysis of 1,1-Dioxoisothiazole and Benzo[b]thiophene-1,1-dioxide Derivatives as Novel Inhibitors of Hepatitis C Virus NS5B Polymerase

  2009cited by this paper
• 3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymerase.

  2009cited by this paper
• Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes?

  2008cited by this paper
• The importance of the domain of applicability in QSAR modeling.

  2008cited by this paper
• Multiple Allosteric Pockets of HCV NS5B Polymerase and its Inhibitors: A Structure Based Insight

  2008cited by this paper
• Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus Polymerase Inhibitors

  2007cited by this paper
• Molecular field technology applied to virtual screening and finding the bioactive conformation

  2007cited by this paper
• Specifically targeted antiviral therapy for hepatitis C virus.

  2007cited by this paper
• Identification of a series of novel derivatives as potent HCV inhibitors by a ligand-based virtual screening optimized procedure.

  2007cited by this paper
• Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors.

  2006cited by this paper
• Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

  2006cited by this paper
• MolDock: a new technique for high-accuracy molecular docking.

  2006cited by this paper
• PMF scoring revisited.

  2006cited by this paper
• A Novel, Highly Selective Inhibitor of Pestivirus Replication That Targets the Viral RNA-Dependent RNA Polymerase

  2006cited by this paper
• Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides.

  2006cited by this paper
• Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation

  2006cited by this paper
• Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site.

  2006cited by this paper
• Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring.

  2006cited by this paper
• Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4.

  2005cited by this paper
• Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-heteroalkyl-4-hydroxyquinolon-3-yl-benzothiadiazines.

  2005cited by this paper
• LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters

  2005cited by this paper
• Molecular interaction fields : applications in drug discovery and ADME prediction

  2005cited by this paper
• Incorporating molecular shape into the alignment-free Grid-Independent Descriptors.

  2004cited by this paper
• A docking score function for estimating ligand-protein interactions: application to acetylcholinesterase inhibition.

  2004cited by this paper
• GEMDOCK: A generic evolutionary method for molecular docking

  2004cited by this paper
• Guided docking approaches to structure-based design and screening.

  2004cited by this paper
• Topomer CoMFA: a design methodology for rapid lead optimization.

  2003cited by this paper
• SuperStar: comparison of CSD and PDB-based interaction fields as a basis for the prediction of protein-ligand interactions.

  2001cited by this paper
• New Linear Interaction Method for Binding Affinity Calculations Using a Continuum Solvent Model

  2001cited by this paper
• GRID/CPCA: a new computational tool to design selective ligands.

  2000cited by this paper
• Analysis of a Large Structure/Biological Activity Data Set Using Recursive Partitioning

  1999cited by this paper
• Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes

  1997cited by this paper
• Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans

  1997cited by this paper
• Scoring noncovalent protein-ligand interactions: A continuous differentiable function tuned to compute binding affinities

  1996cited by this paper
• Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming.

  1995cited by this paper
• The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

  1994cited by this paper
• Extended electron distributions applied to the molecular mechanics of some intermolecular interactions

  1994cited by this paper
• A new method for predicting binding affinity in computer-aided drug design.

  1994cited by this paper
• DREIDING: A generic force field for molecular simulations

  1990cited by this paper
• A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.

  1985cited by this paper
• Facile Syntheses of 2H-1,2,4-Benzothiadiazine 1,1-Dioxides and 4-Oxo-3,4-dihydroquinazolines from 2-Aminobenzenesulfonamide or 2-Aminobenzamide and Aldehydes in the Presence of Sodium Hydrogen Sulfite

  1981cited by this paper
• The Reduction of Nitroarenes with Iron/Acetic Acid

  1977cited by this paper

• Synthesis and molecular docking studies of novel tricyclic and angular tetracyclic benzothiadiazines via sp3‐C‐Hactivation as potential colon cancer inhibitors

  2023cites this paper
• Synthesis and Characterization of Related Substances of Torasemide

  2022cites this paper
• Discovery of Novel HCV NS5B polymerase inhibitor, 2‐(3,4‐dimethyl‐5,5‐dioxidobenzo[e]pyrazolo[4,3‐c][1,2]thiazin‐2(4H)‐yl)‐N‐(2‐fluorobenzyl)acetamide via molecular docking and experimental approach

  2021cites this paper
• The novel scaffold 1,2,4-benzothiadiazine-1,1-dioxide: a review

  2020cites this paper
• The novel scaffold 1,2,4-benzothiadiazine-1,1-dioxide: a review

  2020cites this paper
• A Million Crystal Structures: The Whole Is Greater than the Sum of Its Parts.

  2019cites this paper
• Pyridazine Derivatives as HCV Polymerase Inhibitors: A Drug Discovery for the Treatment of Hepatitis C Virus Infection

  2018influential citation
• Handling Hydrogen Peroxide Oxidations on a Large Scale: Synthesis of 5-Bromo-2-nitropyridine

  2017cites this paper
• Metal-free sequential dual oxidative amination of C(sp3)–H bonds: A direct approach to benzothiadiazine 1,1-dioxide derivatives

  2017cites this paper
• Searching for anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors through a combination of molecular docking, 3D-QSAR and virtual screening

  2016cites this paper
• Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors.

  2015cites this paper
• Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.

  2014cites this paper
• HCV-targeted antivirals: current status and future challenges.

  2014cites this paper
• Accounting for Target Flexibility and Water Molecules by Docking to Ensembles of Target Structures: The HCV NS5B Palm Site I Inhibitors Case Study

  2014cites this paper
• Alternative Approach to Synthesis of 3-(4-chloro butyl)-1H-indole-5-carbonitrile: A Key Intermediate of Vilazodone Hydrochloride, an Antidepressant Drug

  2014cites this paper
• Ligand design, synthesis and biological anti-HCV evaluations for genotypes 1b and 4a of certain 4-(3- & 4-[3-(3,5-dibromo-4-hydroxyphenyl)-propylamino]phenyl) butyric acids and 3-(3,5-dibromo-4-hydroxyphenyl)-propylamino-acetamidobenzoic acid esters

  2013cites this paper
• Molecular interaction fields in drug discovery: recent advances and future perspectives

  2013cites this paper
• Synthesis and Molecular Modeling Studies of Bicyclic Inhibitors of Dihydrofolate Reductase, Receptor Tyrosine Kinases and Tubulin

  2013cites this paper
• Combinatorial chemistry online volume 14, issue 9, September 2012

  2012cites this paper